Cargando…

Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403

This study aimed to evaluate the impact of pretreatment C-reactive protein (CRP) and skeletal muscle mass (SMM) on outcomes after stereotactic body radiotherapy (SBRT) for T1N0M0 non-small cell lung cancer (NSCLC) as a supplementary analysis of JCOG0403. Patients were divided into high and low CRP g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuo, Yukinori, Nagata, Yasushi, Wakabayashi, Masashi, Ishikura, Satoshi, Onishi, Hiroshi, Kokubo, Masaki, Karasawa, Katsuyuki, Shioyama, Yoshiyuki, Onimaru, Rikiya, Hiraoka, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Oncology/Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438483/ https://www.ncbi.nlm.nih.gov/pubmed/34350956 http://dx.doi.org/10.1093/jrr/rrab065

Ejemplares similares

Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702)
por: Onimaru, Rikiya, et al.
Publicado: (2018)

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0702)
por: Nishio, Teiji, et al.
Publicado: (2014)

Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502
por: Mitani, Seiichiro, et al.
Publicado: (2022)

Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study
por: Iizuka, Yusuke, et al.
Publicado: (2023)

Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects
por: Niibe, Yuzuru, et al.
Publicado: (2016)

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
por: Nakamura, Nobuhiko, et al.
Publicado: (2021)

Comparative Analysis of Photon Stereotactic Radiotherapy and Carbon-Ion Radiotherapy for Elderly Patients with Stage I Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study
por: Aoki, Shuri, et al.
Publicado: (2023)

Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408)
por: Kawahara, Daisuke, et al.
Publicado: (2017)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database
por: Shioyama, Yoshiyuki, et al.
Publicado: (2018)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence
por: Inoue, Tetsuya, et al.
Publicado: (2012)

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
por: Narabayashi, Masaru, et al.
Publicado: (2012)

Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303
por: Tsushima, Takahiro, et al.
Publicado: (2016)

Differences in the dose–volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer
por: Ueki, Nami, et al.
Publicado: (2013)

Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study
por: Nozaki, Isao, et al.
Publicado: (2015)

Erratum to: Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study
por: Nozaki, Isao, et al.
Publicado: (2015)

Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis–4N0M0 Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
por: Nemoto, Takafumi, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview
por: Matsuo, Yukinori
Publicado: (2023)

P1220: CHARACTERISTICS OF SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA – A SUPPLEMENTARY ANALYSIS OF JCOG0601
por: Shimada, K., et al.
Publicado: (2022)

Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)
por: Shinoda, Masayuki, et al.
Publicado: (2015)

Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
por: Yamashita, Hideomi, et al.
Publicado: (2015)

P04.03. Primary care providers’ attitudes and beliefs about, and personal use of, complementary and alternative medicine (CAM)
por: George, M, et al.
Publicado: (2012)

Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303)
por: Okuno, Tatsuya, et al.
Publicado: (2017)

The impact of the COVID-19 pandemic on radiotherapy in Japan: nationwide surveys from May 2020 through June 2021
por: Tamari, Keisuke, et al.
Publicado: (2022)

Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001)
por: Kawakami, Takeshi, et al.
Publicado: (2022)

OA04.03. Neural responses to the mechanical characteristics of a spinal manipulation: effect of varying direction of the applied thrust force
por: Pickar, J, et al.
Publicado: (2012)

Sacral insufficiency fracture after stereotactic body radiation therapy for sacral metastasis
por: Kawamoto, Terufumi, et al.
Publicado: (2018)

Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910
por: Shida, Dai, et al.
Publicado: (2023)

HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1)
por: Ri, Masaki, et al.
Publicado: (2021)

Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study
por: Gomez-Gaitan, Esteban Alejandro, et al.
Publicado: (2023)

Similar-Case-Based Optimization of Beam Arrangements in Stereotactic Body Radiotherapy for Assisting Treatment Planners
por: Magome, Taiki, et al.
Publicado: (2013)

P1520: PROGNOSTIC IMPACT OF FEBRILE NEUTROPENIA AND DOSE INTENSITY OF R-CHOP THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, A SUPPLEMENTARY ANALYSIS OF JCOG0601
por: Yoshida, Isao, et al.
Publicado: (2023)

Stereotactic body radiotherapy for T3 and T4N0M0 non–small cell lung cancer
por: Eriguchi, Takahisa, et al.
Publicado: (2016)

Stereotactic ablative radiotherapy for inoperable T1‐2N0M0 small‐cell lung cancer
por: Tang, Hui, et al.
Publicado: (2022)

Impact of multileaf collimator width on intraprostatic dose painting plans for dominant intraprostatic lesion of prostate cancer
por: Abe, Eisuke, et al.
Publicado: (2010)

Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2023)

The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer
por: Mampuya, Wambaka Ange, et al.
Publicado: (2014)

A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer
por: Matsuo, Yukinori
Publicado: (2018)

On the Feasibility of Stereotactic Radiosurgery With 5.0 and 10.0 mm MLC Leaves as a Function of Target Size and Shape
por: Jalbout, Wassim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rdgs8v8817bn2n6do05qno3s79